These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Thyrotropin receptor antibodies and Graves' disease, a side-effect of 131I treatment in patients with nontoxic goiter. Nygaard B; Knudsen JH; Hegedüs L; Scient AV; Hansen JE J Clin Endocrinol Metab; 1997 Sep; 82(9):2926-30. PubMed ID: 9284721 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the 2nd generation radio-receptional assay for anti-TSH receptor antibodies (TRAb) in autoimmune thyroid diseases. Comparison with 1st generation and anti-thyroperoxidase antibodies (AbTPO). Giovanella L; Ceriani L; Garancini S Q J Nucl Med; 2001 Mar; 45(1):115-9. PubMed ID: 11456370 [TBL] [Abstract][Full Text] [Related]
4. Assays of TSH-receptor antibodies in 576 patients with various thyroid disorders: their incidence, significance and clinical usefulness. Macchia E; Concetti R; Borgoni F; Cetani F; Fenzi GF; Pinchera A Autoimmunity; 1989; 3(2):103-12. PubMed ID: 2577491 [TBL] [Abstract][Full Text] [Related]
5. Disseminated thyroid autonomy or Graves' disease: reevaluation by a second generation TSH receptor antibody assay. Meller J; Jauho A; Hüfner M; Gratz S; Becker W Thyroid; 2000 Dec; 10(12):1073-9. PubMed ID: 11201852 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of a coated-tube assay for antithyrotropin receptor antibodies in patients with Graves' disease and other thyroid disorders. Cardia MS; Lima N; Knobel M; Medeiros-Neto G Thyroid; 2004 Apr; 14(4):295-300. PubMed ID: 15142363 [TBL] [Abstract][Full Text] [Related]
7. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease. Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE; Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913 [TBL] [Abstract][Full Text] [Related]
8. TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays. Pedersen IB; Knudsen N; Perrild H; Ovesen L; Laurberg P Clin Endocrinol (Oxf); 2001 Sep; 55(3):381-90. PubMed ID: 11589682 [TBL] [Abstract][Full Text] [Related]
9. Distinction between autoimmune and non-autoimmune hyperthyroidism by determination of TSH-receptor antibodies in patients with the initial diagnosis of toxic multinodular goiter. Wallaschofski H; Orda C; Georgi P; Miehle K; Paschke R Horm Metab Res; 2001 Aug; 33(8):504-7. PubMed ID: 11544566 [TBL] [Abstract][Full Text] [Related]
10. Improved prediction of relapse of Graves' thyrotoxicosis by combined determination of TSH receptor and thyroperoxidase antibodies. Schott M; Eckstein A; Willenberg HS; Nguyen TB; Morgenthaler NG; Scherbaum WA Horm Metab Res; 2007 Jan; 39(1):56-61. PubMed ID: 17226115 [TBL] [Abstract][Full Text] [Related]
11. [Diagnostic value of thyroid antibodies]. Toldy E; Lócsei Z; Kalmár I; Varga L; Kovács LG Orv Hetil; 1996 Sep; 137(38):2075-80. PubMed ID: 8966023 [TBL] [Abstract][Full Text] [Related]
12. Comparison of a solid phase human- versus porcine- thyrotropin receptor-based immunoassay for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases. Hermsen D; Liu C; Domberg J; Graeber C; Feldkamp J; Duan Y; Xu K; Liu C; Mao X; Scherbaum WA; Schott M Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S59-63. PubMed ID: 18777457 [TBL] [Abstract][Full Text] [Related]
13. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre. Wallaschofski H; Kuwert T; Lohmann T Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319 [TBL] [Abstract][Full Text] [Related]
14. Clinical value of the first automated TSH receptor autoantibody assay for the diagnosis of Graves' disease (GD): an international multicentre trial. Schott M; Hermsen D; Broecker-Preuss M; Casati M; Mas JC; Eckstein A; Gassner D; Golla R; Graeber C; van Helden J; Inomata K; Jarausch J; Kratzsch J; Miyazaki N; Moreno MA; Murakami T; Roth HJ; Stock W; Noh JY; Scherbaum WA; Mann K Clin Endocrinol (Oxf); 2009 Oct; 71(4):566-73. PubMed ID: 19170704 [TBL] [Abstract][Full Text] [Related]
15. [Thyrotropin receptor antibodies (TRAb) as a test of surgical treatment effectiveness in Graves-Basedow's diseases]. Bojarska-Szmygin A; Ciechanek R; Jezierska B; Zaorska-Rajca J Pol Merkur Lekarski; 2002 Sep; 13(75):196-9. PubMed ID: 12474569 [TBL] [Abstract][Full Text] [Related]
16. [TSH anti-receptor antibodies in Graves' disease]. Sérgio MR; Godinho C; Guerra L; Agapito A; Fonseca F; Costa C Acta Med Port; 1996; 9(7-9):229-31. PubMed ID: 9005701 [TBL] [Abstract][Full Text] [Related]
17. Anti-TSH receptor antibodies in clinical practice. Orgiazzi J Endocrinol Metab Clin North Am; 2000 Jun; 29(2):339-55, vii. PubMed ID: 10874533 [TBL] [Abstract][Full Text] [Related]
18. Comparison of autoantibodies level in thyroid autoimmune diseases estimated by different methods. Gardas A; Blottner A; Domek H Exp Clin Endocrinol; 1988 Sep; 92(1):77-84. PubMed ID: 3229451 [TBL] [Abstract][Full Text] [Related]
19. Performance of a third-generation TSH-receptor antibody in a UK clinic. Theodoraki A; Jones G; Parker J; Woolman E; Martin N; Perera S; Thomas M; Bunn C; Khoo B; Bouloux PM; Vanderpump MP Clin Endocrinol (Oxf); 2011 Jul; 75(1):127-33. PubMed ID: 21521291 [TBL] [Abstract][Full Text] [Related]
20. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies. Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]